Search CDMOs

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

• CMC Analytical Development
• Cell-Line Development
• CMC Regulatory Submission Support

GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.

• CMC Analytical Development
• Controlled Substance Manufacturing
• Sterile Fill-Finish & Aseptic Manufacturing

Drug product CDMO specializing in aseptic injectables, oral solid dose, lyophilization, and prefilled syringes with 30+ years of experience in complex formulations and potent compounds; now part of Jabil.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

U.S. pharmaceutical CDMO offering design, development, and manufacturing from early formulation to commercial-scale production, with cGMP capabilities including spray drying, particle engineering, and complex oral dosage forms.

• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing
• Formulation Development

Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.

• CMC Analytical Development
• Cartridge Filling
• CMC Regulatory Submission Support

Purpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines.

• CMC Analytical Development
• Cartridge Filling
• Cold-Chain Storage & Logistics

Bloomington-based CDMO specializing in aseptic filling of small-volume parenterals (vials, syringes, cartridges), formulation development, QC testing, and supply chain management with GMP-compliant operations.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Sterile injectable CDMO specializing in formulation development, lyophilization, fill/finish, and ADC manufacturing with cGMP-compliant facilities in the U.S. and Germany.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

Award-winning CDMO specializing in commercial manufacturing of oral solids, sterile injectables, and biologic drug products with Pfizer's technical expertise and global network.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

• AAV Manufacturing
• CMC Analytical Development
• Cell-Line Development

Viral vector CDMO specializing in AAV, lentiviral, and retroviral manufacturing for gene and cell therapies, with cGMP facilities in Indiana and Massachusetts supporting preclinical through commercial-scale production.

• CMC Analytical Development
• Cell-Line Development
• Monoclonal Antibody (mAb) Manufacturing

Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.

• AAV Manufacturing
• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development

Cell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.

• AAV Manufacturing
• CMC Analytical Development
• Cell Therapy Manufacturing

Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

• AAV Manufacturing
• CMC Analytical Development
• CMC Regulatory Submission Support

Dedicated AAV gene therapy CDMO with a 200,000+ sq. ft. cGMP facility featuring 20 suites and bioreactors up to 5,000L, supporting 60+ clients across 35+ indications with high-yield manufacturing and seamless regulatory compliance.

• CMC Analytical Development
• Cell-Line Development
• Cell Therapy Manufacturing

Advanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale.